Jaguar Health exchanges $6.73M Streeterville debt for 729,989 shares at ~$9.22; 2025 Note fully cancelled

Jaguar Health, Inc.

2021 Note exchange: issued 182,091 shares to Streeterville for a $1,678,320 reduction of the secured note originally issued Jan. 19, 2021 with a $6,220,812.50 principal.
2025 Note exchange: issued 547,898 shares for a $5,049,909.26 reduction, fully paying off and cancelling the $10,810,000 note issued Nov. 12, 2025.
Implied exchange price of roughly $9.22/share on 729,989 total new shares, versus ~1,463,958 shares outstanding as of Sept. 24, 2026 — about 50% dilution.
Shares delivered via DWAC free of restrictive legends, issued under the Section 3(a)(9) exemption; Streeterville capped at 9.99% beneficial ownership.
Original 2021 Note remains in force for its remaining balance; Streeterville is the noteholder and counterparty, Lisa A. Conte signed as Jaguar CEO.

item 1.01 item 1.02 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.